NO20074262L - Anthelmintisk sammensetning - Google Patents

Anthelmintisk sammensetning

Info

Publication number: NO20074262L
Authority: NO; Norway
Prior art keywords: active ingredient; carrier; formulation; anthelmintic composition; chlorosulon
Prior art date: 2005-01-21

Application number

NO20074262A

Other languages

English (en)

Norwegian (no)

Inventor

William Blakely

Lillian Cromie

Original Assignee

Norbrook Lab Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-01-21

Filing date

2007-08-21

Publication date

2007-08-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34259424&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074262(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-08-21 Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd

2007-08-21 Publication of NO20074262L publication Critical patent/NO20074262L/no

Links

230000000507 anthelmentic effect Effects 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 2
AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 abstract 1
SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 abstract 1
239000005660 Abamectin Substances 0.000 abstract 1
RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 abstract 1
241001468227 Streptomyces avermitilis Species 0.000 abstract 1
230000001476 alcoholic effect Effects 0.000 abstract 1
RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
229960002418 ivermectin Drugs 0.000 abstract 1
150000002596 lactones Chemical class 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
229960000502 poloxamer Drugs 0.000 abstract 1
229920001983 poloxamer Polymers 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
238000011200 topical administration Methods 0.000 abstract 1
239000012049 topical pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Tropical Medicine & Parasitology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20074262A 2005-01-21 2007-08-21 Anthelmintisk sammensetning NO20074262L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0501220.8A GB0501220D0 (en)	2005-01-21	2005-01-21	Anthelmintic composition
PCT/GB2006/000211 WO2006077429A1 (en)	2005-01-21	2006-01-19	Anthelmintic composition

Publications (1)

Publication Number	Publication Date
NO20074262L true NO20074262L (no)	2007-08-21

Family

ID=34259424

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20074262A NO20074262L (no)	2005-01-21	2007-08-21	Anthelmintisk sammensetning

Country Status (30)

Country	Link
US (1)	US20080206378A1 (de)
EP (1)	EP1838295B1 (de)
JP (1)	JP5094414B2 (de)
KR (1)	KR20070094979A (de)
CN (1)	CN101107002B (de)
AP (1)	AP2753A (de)
AR (1)	AR052882A1 (de)
AT (1)	ATE452628T1 (de)
AU (1)	AU2006207326B2 (de)
BR (1)	BRPI0606429A2 (de)
CA (1)	CA2594981C (de)
CR (1)	CR9259A (de)
CY (1)	CY1109885T1 (de)
DE (1)	DE602006011271D1 (de)
DK (1)	DK1838295T3 (de)
EA (1)	EA012284B1 (de)
ES (1)	ES2337177T3 (de)
GB (1)	GB0501220D0 (de)
IL (1)	IL184737A (de)
MX (1)	MX2007008750A (de)
NO (1)	NO20074262L (de)
NZ (1)	NZ556537A (de)
PE (1)	PE20060908A1 (de)
PL (1)	PL1838295T3 (de)
PT (1)	PT1838295E (de)
SI (1)	SI1838295T1 (de)
TN (1)	TNSN07285A1 (de)
UY (1)	UY29342A1 (de)
WO (1)	WO2006077429A1 (de)
ZA (1)	ZA200705882B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IES20070395A2 (en) *	2006-12-05	2008-06-11	Michael Hilary Burke	A process for the preparation of a stable anhydrous anthelmintic formulation
WO2009070687A1 (en) *	2007-11-26	2009-06-04	Merial Limited	Solvent systems for pour-on formulations for combating parasites
AU2013201461B2 (en) *	2007-11-26	2015-10-29	Boehringer Ingelheim Animal Health USA Inc.	Solvent systems for pour-on formulations for combating parasites
GB201021836D0 (en) *	2010-12-21	2011-02-02	Norbrook Lab Ltd	Topical Composition
NZ702107A (en) *	2012-05-03	2016-02-26	Norbrook Lab Ltd	Avermectin pour-on formulation with reduced withdrawal time
AR116524A1 (es) *	2018-10-04	2021-05-19	Elanco Tiergesundheit Ag	Potenciación de tratamiento de helmintos
PY2013845A (es) *	2019-03-01	2021-02-09	Boehringer Ingelheim Animal Health Usa Inc	Composiciones inyectables de clorsulón, sus métodos y usos
CN113598163A (zh) *	2021-09-10	2021-11-05	姜兆伟	一种防儿童误食的蚊香液及原料苦精的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3987199A (en) *	1973-01-26	1976-10-19	Merck & Co., Inc.	Substituted benzenesulfonamides as anthelmintics
US4336262A (en) *	1973-02-23	1982-06-22	Fisons Ltd.	Pour-on veterinary anthelmintic
NL180633C (nl) *	1973-06-22	1900-01-01	Bayer Ag	Werkwijze ter bereiding van een anthelmintisch werkzaam veterinair opgiet-preparaat.
US3953492A (en) *	1975-03-27	1976-04-27	Merck & Co., Inc.	Anthelmintic substituted sulfonamide derivatives
US4065239A (en) *	1975-10-17	1977-12-27	Philip Morris, Inc.	Jam prevention device for extrusion process
SE434277B (sv) *	1976-04-19	1984-07-16	Merck & Co Inc	Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
NZ207655A (en) *	1983-04-07	1986-09-10	Merck & Co Inc	Synergistic veterinary compositions containing an avermectin compound and clorsulon
JPH0678342B2 (ja) *	1986-01-07	1994-10-05	三共株式会社	新規マクロライド化合物
US5053227A (en) *	1989-03-22	1991-10-01	Cygnus Therapeutic Systems	Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
ES2202324T3 (es) *	1993-05-10	2004-04-01	MERCK & CO., INC.	Formulaciones de vertido que contienen material polimerico, glicoles y gliceridos.
US5602107A (en) *	1993-05-10	1997-02-11	Merck & Co., Inc.	Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
US5773422A (en) *	1996-01-29	1998-06-30	Komer; Gene	Avermectin formulation
AUPQ875700A0 (en) *	2000-07-13	2000-08-03	Reflex Research Limited	Combination compositions
US20030064941A1 (en) *	2001-05-21	2003-04-03	Pfizer Inc.	Avermectin and praziquantel combination therapy
US6627613B2 (en) *	2001-07-23	2003-09-30	Michael A. Strobel	Application of water and organic solvent soluble ivermectin for topical and oral use
UA82359C2 (uk) *	2003-04-03	2008-04-10	Schering Plough Ltd	Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
PE20050386A1 (es) *	2003-05-29	2005-06-23	Schering Plough Ltd	Composiciones farmaceuticas de florfenicol
GB0316377D0 (en) *	2003-07-12	2003-08-13	Norbrook Lab Ltd	Parasiticidal composition
US7514464B2 (en) *	2003-12-18	2009-04-07	Pfizer Limited	Substituted arylpyrazoles
EP1811841B1 (de) *	2004-11-19	2009-10-28	Schering-Plough Ltd.	Kontrolle von parasiten bei tieren mittels verwendung von parasitiziden 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitril-derivaten

2005
- 2005-01-21 GB GBGB0501220.8A patent/GB0501220D0/en not_active Ceased
2006
- 2006-01-19 JP JP2007551747A patent/JP5094414B2/ja not_active Expired - Fee Related
- 2006-01-19 US US11/813,627 patent/US20080206378A1/en not_active Abandoned
- 2006-01-19 MX MX2007008750A patent/MX2007008750A/es active IP Right Grant
- 2006-01-19 AP AP2007004083A patent/AP2753A/xx active
- 2006-01-19 EP EP06700797A patent/EP1838295B1/de not_active Revoked
- 2006-01-19 DE DE602006011271T patent/DE602006011271D1/de not_active Expired - Lifetime
- 2006-01-19 PL PL06700797T patent/PL1838295T3/pl unknown
- 2006-01-19 DK DK06700797.1T patent/DK1838295T3/da active
- 2006-01-19 AU AU2006207326A patent/AU2006207326B2/en not_active Ceased
- 2006-01-19 AT AT06700797T patent/ATE452628T1/de active
- 2006-01-19 WO PCT/GB2006/000211 patent/WO2006077429A1/en not_active Ceased
- 2006-01-19 CA CA2594981A patent/CA2594981C/en not_active Expired - Fee Related
- 2006-01-19 BR BRPI0606429-9A patent/BRPI0606429A2/pt not_active Application Discontinuation
- 2006-01-19 ES ES06700797T patent/ES2337177T3/es not_active Expired - Lifetime
- 2006-01-19 SI SI200630573T patent/SI1838295T1/sl unknown
- 2006-01-19 EA EA200701542A patent/EA012284B1/ru not_active IP Right Cessation
- 2006-01-19 KR KR1020077019118A patent/KR20070094979A/ko not_active Ceased
- 2006-01-19 CN CN2006800026448A patent/CN101107002B/zh not_active Expired - Fee Related
- 2006-01-19 NZ NZ556537A patent/NZ556537A/en not_active IP Right Cessation
- 2006-01-19 PT PT06700797T patent/PT1838295E/pt unknown
- 2006-01-20 PE PE2006000088A patent/PE20060908A1/es not_active Application Discontinuation
- 2006-01-20 AR ARP060100210A patent/AR052882A1/es unknown
- 2006-01-23 UY UY29342A patent/UY29342A1/es not_active Application Discontinuation
2007
- 2007-07-18 ZA ZA200705882A patent/ZA200705882B/xx unknown
- 2007-07-18 CR CR9259A patent/CR9259A/es unknown
- 2007-07-19 IL IL184737A patent/IL184737A/en not_active IP Right Cessation
- 2007-07-20 TN TNP2007000285A patent/TNSN07285A1/en unknown
- 2007-08-21 NO NO20074262A patent/NO20074262L/no not_active Application Discontinuation
2010
- 2010-03-11 CY CY20101100236T patent/CY1109885T1/el unknown

Also Published As

Publication number	Publication date
CR9259A (es)	2007-11-23
MX2007008750A (es)	2008-02-19
JP2008528472A (ja)	2008-07-31
PE20060908A1 (es)	2006-09-04
UY29342A1 (es)	2006-10-02
AU2006207326B2 (en)	2011-04-14
BRPI0606429A2 (pt)	2010-01-19
CY1109885T1 (el)	2014-09-10
US20080206378A1 (en)	2008-08-28
WO2006077429A1 (en)	2006-07-27
PT1838295E (pt)	2010-03-18
ZA200705882B (en)	2008-08-27
EP1838295A1 (de)	2007-10-03
CA2594981A1 (en)	2006-07-27
JP5094414B2 (ja)	2012-12-12
GB0501220D0 (en)	2005-03-02
HK1116047A1 (en)	2008-12-19
NZ556537A (en)	2010-04-30
TNSN07285A1 (en)	2008-12-31
CN101107002A (zh)	2008-01-16
CN101107002B (zh)	2011-07-20
IL184737A (en)	2015-07-30
AP2007004083A0 (en)	2007-08-31
AP2753A (en)	2013-09-30
PL1838295T3 (pl)	2010-05-31
KR20070094979A (ko)	2007-09-27
AR052882A1 (es)	2007-04-11
IL184737A0 (en)	2007-12-03
EP1838295B1 (de)	2009-12-23
SI1838295T1 (sl)	2010-04-30
DE602006011271D1 (de)	2010-02-04
EA200701542A1 (ru)	2007-12-28
CA2594981C (en)	2014-05-13
AU2006207326A1 (en)	2006-07-27
EA012284B1 (ru)	2009-08-28
WO2006077429A8 (en)	2006-12-28
ATE452628T1 (de)	2010-01-15
ES2337177T3 (es)	2010-04-21
DK1838295T3 (da)	2010-05-03

Legal Events

Date	Code	Title	Description
2014-08-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
CY1109885T1 (el)	2014-09-10	Ανθελμινθικη συνθεση
CY1119839T1 (el)	2018-06-27	Στερεες μορφες δοσεως μπενταμουστινης
MX2010004222A (es)	2010-09-14	Formulaciones solidas de compuestos cristalinos.
BR9808581A (pt)	2000-05-30	Estabilização de benzimidazóis sensìveis a ácido com combinações de aminoácido/ciclodextrina
CY1109117T1 (el)	2014-07-02	Διαμορφωσεις enaιωphmatoς, οι οποιες περιλαμβανουν δραστικον συστατικο, επιφανειακως δρωσαν ουσια poloxamer ή meroxapol και γλυκολη, χρησις του δια την βιομηχανικην παρασκευην φαρμακου προς νοσηλειαν οφθαλμικων διαταραχων
BRPI0411171A (pt)	2006-07-18	derivados de carboidratos de rapamicina, composição farmacêutica, método para o tratamento de uma doença tratável por rapamicina e dispositivo médico
EA200870379A1 (ru)	2009-04-28	Фармацевтическая композиция с замедленным высвобождением на основе системы высвобождения, включающей кислоторастворимый полимер и ph-зависимый полимер
BRPI0418098A (pt)	2007-04-17	formulações veterinárias não contendo produtos animais
TW200621238A (en)	2006-07-01	Pharmaceutical formulation
BRPI0615860B8 (pt)	2021-05-25	composição farmacêutica de liberação prolongada monolítica sólida
AU2008282388A1 (en)	2009-02-05	Endoparasiticidal topical compositions
PH12021550477A1 (en)	2021-11-22	Sustained-release injectable antibiotical formulation
CY1107819T1 (el)	2013-06-19	Φαρμακευτικη διαμορφωση της ολανζαπινης
WO2007124700A3 (en)	2007-12-21	Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
WO2007037874A3 (en)	2007-11-08	Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear
AR064152A1 (es)	2009-03-18	Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion.
US10307405B2 (en)	2019-06-04	Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles
BRPI0418427A (pt)	2007-06-12	formulações farmacêuticas de matriz semi-sólida
BRPI0506630A (pt)	2007-05-08	composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada
BRPI0510906A (pt)	2007-11-06	composição farmacêutica tópica, composição para administração tópica e seu uso
CA2622713A1 (en)	2007-03-22	Anthelmintic formulations
AU2013204176B2 (en)	2016-06-02	Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles
CL2025001049A1 (es)	2025-08-08	Sistema de administración de ingrediente activo
PE20242349A1 (es)	2024-12-16	Composicion en espray nasal bioadhesivo, proceso de preparacion y uso
EP3595441A1 (de)	2020-01-22	Stabile topische veterinärmedizinische zusammensetzung